The purpose of the study is to develop an acceptable, feasible, and effective peer-led bundle of health resilience and promotion services to be delivered in the hospital setting, called the THRIVE intervention. The main question it aims to answer is: Will participants receiving the THRIVE intervention have a reduced risk of self-reported non-fatal overdoses OR skin/soft tissue infections compared to participants receiving enhanced usual care? Researchers will compare the THRIVE model to enhanced usual care to see if the THRIVE model helps participants reduce their number of self-reported non-fatal overdoses OR skin/soft tissue infections. Intervention participants will: * Receive one in-person session from a peer support specialist while in the hospital * Receive weekly text messages from the peer support specialist for a 12-week period * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants Enhanced usual care participants will: * Receive a handout with health resilience education and resources in their local area * Receive monthly, multiple-choice assessments via text message at Month 1, 2, 3, 4, 5, and 6 * Complete a baseline, 3-month, and 6-month assessment with Research Assistants
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
390
Participants will receive one peer-led, in-person session boosted by weekly text messages over a 12-week period.
Participants will receive a handout that includes health resilience education and resources in their local area as part of enhanced usual care.
UPMC Mercy Hospital
Pittsburgh, Pennsylvania, United States
NOT_YET_RECRUITINGUPMC Presbyterian-Montefiore Hospital
Pittsburgh, Pennsylvania, United States
RECRUITINGUPMC Shadyside Hospital
Pittsburgh, Pennsylvania, United States
NOT_YET_RECRUITINGEffectiveness of the THRIVE intervention compared to enhanced usual care (EUC) at lowering the incidence of non-fatal overdoses OR skin and soft tissue infections
Cumulative incidence of non-fatal overdose OR skin and soft tissue infection
Time frame: Baseline to 6 months
Effectiveness of the THRIVE intervention compared to EUC at lowering the incidence of non-fatal overdoses
Cumulative incidence of non-fatal overdose
Time frame: Baseline to 6 months
Effectiveness of the THRIVE intervention compared to EUC at lowering the incidence of skin and soft tissue infections
Cumulative incidence of skin and soft tissue infection
Time frame: Baseline to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.